ImageneBio Inc
46 hedge funds and large institutions have $106M invested in ImageneBio Inc in 2022 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 6 increasing their positions, 19 reducing their positions, and 15 closing their positions.
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
0.17% less ownership
Funds ownership: 6.34% → 6.17% (-0.17%)
7% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 15
4% less funds holding
Funds holding: 48 → 46 (-2)
37% less capital invested
Capital invested by funds: $168M → $106M (-$62.1M)
68% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 19
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Verition Fund Management
Greenwich,
Connecticut
|
+$4.7M |
| 2 |
LCM
Laurion Capital Management
New York
|
+$2.43M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$1.56M |
| 4 |
CA
CHI Advisors
New York
|
+$1.27M |
| 5 |
Millennium Management
New York
|
+$1.08M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$5.54M |
| 2 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$2.31M |
| 3 |
State Street
Boston,
Massachusetts
|
-$1.66M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.24M |
| 5 |
LGM
Logos Global Management
San Francisco,
California
|
-$1.09M |
IMA Hedge Fund Activity: Q2 2022 in Review
46 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in ImageneBio Inc (IMA) for Q2 2022, worth a combined $106M — down 37% from $168M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of IMA and 14 opened new positions — a net loss of 1 holder — while 19 trimmed existing stakes and 6 added.
The largest buyer was Verition Fund Management, opening a new position worth an estimated $4.7M. The largest seller was BlackRock, cutting an estimated $5.54M.
- 46 institutional investors held ImageneBio Inc (IMA) as of Q2 2022, down from 48 in Q1 2022.
- Funds reported $106M of ImageneBio Inc stock for Q2 2022, down 37% quarter-over-quarter.
- 14 funds opened new ImageneBio Inc positions in Q2 2022 and 15 closed out, a net change of -1 holder.
- The largest ImageneBio Inc buyer in Q2 2022 was Verition Fund Management, an estimated $4.7M added.
- The largest ImageneBio Inc seller in Q2 2022 was BlackRock, an estimated $5.54M sold.
Based on aggregated 13F filings for Q2 2022.